Moreover, there are some IFs associated with clinical actionability similar to disease genes included on the ACMG SF lists (e.g., ABCD1-related adrenoleukodystrophy, patient 1, Table 2). This evidence concerns the gene ABCD1 and adrenoleukodystrophy.